Chemical Compound

Cyclophosphamide regimen with etoposide, hydroxydaunorubicin, oncovin and prednisone

Cyclophosphamide regimen with etoposide, hydroxydaunorubicin, oncovin and prednisone 结构式
Primary record

Cyclophosphamide regimen with etoposide, hydroxydaunorubicin, oncovin and prednisone

库存
550 克
纯度
98.1 %

化合物标识与属性

PubChem CID
56841998
SMILES
CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C6=C(C=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)OC3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O.C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C.C1CNP(=O)(OC1)N(CCCl)CCCl
Canonical SMILES
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3ccc4c(c3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.COc1cc([C@@H]2c3cc4c(cc3C(O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO.O=P1(N(CCCl)CCCl)NCCCO1

名称与同义词

  • EPOCH protocol
  • Epoch
  • CAVPE protocol
  • CHOPE protocol
  • VACPE protocol
  • EPOCH regimen
  • CHOP-E protocol
  • EPOCH [regimen]
  • DA-EPOCH protocol
  • dose-adjusted EPOCH protocol
  • SCHEMBL29932494
  • CID:56841998
  • SID:53789634
  • C079446
  • C079446000
  • Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin regimen
  • Cyclophosphamide regimen with etoposide, hydroxydaunorubicin, oncovin and prednisone
  • Etoposide / Prednisone / Oncovin / Cyclophosphamide / Hydroxydaunorubicin regimen